AI04: A Novel Machine Learning Software Application for Prognosticating Cutaneous Malignant Melanoma Based on Data from 78,351 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database

    Mohamed Mortagy, Nikita Cliff-Patel, Alina Bologan, Regina Askary
    Studysummary This study found that an ML model incorporating factors like Breslow thickness and age improved cutaneous malignant melanoma prognosis predictions compared to TNM staging, with a C-index of 80% versus 66.6% for TNM alone, suggesting ML's potential for personalized prognostication.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →